Literature DB >> 16482810

[Congenital transmission of Trypanosoma cruzi infection in Argentina].

Sergio Sosa-Estani1.   

Abstract

Congenital transmission of Trypanosoma cruzi infection in Argentina has being increasing its relative importance with control of vectorial and transfusional transmission growth. It is for this reason that vertical transmission is seen, in the future, as a continuous source of infected newborns, even with vectorial and transfusional transmission completely controlled. Preventing vertical transmission of T.cruzi is not possible, but it can be precociously detected, permitting mother and child to be incorporated into the medical attention system, and so allowing the newbornś treatment with practically 100% efficacy. It is estimated that between 800 and 1700 children infected with T. cruzi by congenital transmission are born in Argentina, per year. The implementation of an early strategy of detection for an effective and opportune treatment acquires great relevance as a Public Health measure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16482810

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  8 in total

1.  Congenital Trypanosoma cruzi transmission in Santa Cruz, Bolivia.

Authors:  Caryn Bern; Manuela Verastegui; Robert H Gilman; Carlos Lafuente; Gerson Galdos-Cardenas; Maritza Calderon; Juan Pacori; Maria Del Carmen Abastoflor; Hugo Aparicio; Mark F Brady; Lisbeth Ferrufino; Noelia Angulo; Sarah Marcus; Charles Sterling; James H Maguire
Journal:  Clin Infect Dis       Date:  2009-12-01       Impact factor: 9.079

2.  Prevalence and risk factors for Chagas disease in pregnant women in Casanare, Colombia.

Authors:  Zulma M Cucunubá; Astrid C Flórez; Angela Cárdenas; Paula Pavía; Marleny Montilla; Rodrigo Aldana; Katherine Villamizar; Lyda C Ríos; Rubén S Nicholls; Concepción J Puerta
Journal:  Am J Trop Med Hyg       Date:  2012-10-01       Impact factor: 2.345

3.  Early diagnosis of congenital Trypanosoma cruzi infection, using shed acute phase antigen, in Ushuaia, Tierra del Fuego, Argentina.

Authors:  María Cristina Mallimaci; Sergio Sosa-Estani; Graciela Russomando; Zunilda Sanchez; Carina Sijvarger; Isabel Marcela Alvarez; Lola Barrionuevo; Carlos Lopez; Elsa Leonor Segura
Journal:  Am J Trop Med Hyg       Date:  2010-01       Impact factor: 2.345

4.  Congenital transmission of Trypanosoma cruzi in Argentina, Honduras, and Mexico: study protocol.

Authors:  Pierre Buekens; Maria-Luisa Cafferata; Jackeline Alger; Fernando Althabe; José M Belizán; Yves Carlier; Alvaro Ciganda; Eric Dumonteil; Rubi Gamboa-Leon; Elizabeth Howard; Maria Luisa Matute; Sergio Sosa-Estani; Carine Truyens; Dawn Wesson; Concepcion Zuniga
Journal:  Reprod Health       Date:  2013-10-11       Impact factor: 3.223

5.  Trypanocide treatment of women infected with Trypanosoma cruzi and its effect on preventing congenital Chagas.

Authors:  Diana L Fabbro; Emmaria Danesi; Veronica Olivera; Maria Olenka Codebó; Susana Denner; Cecilia Heredia; Mirtha Streiger; Sergio Sosa-Estani
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

6.  [Strategy to improve access to etiological treatment of Chagas disease at the first level of care in Argentina].

Authors:  Karen Klein; María Soledad Burrone; Juan Pedro Alonso; Lucila Rey Ares; Sebastián García Martí; Antonia Lavenia; Estela Calderón; Cynthia Spillmann; Sergio Sosa Estani
Journal:  Rev Panam Salud Publica       Date:  2017-05-25

7.  Achievements and challenges upon the implementation of a program for national control of congenital Chagas in Bolivia: results 2004-2009.

Authors:  Cristina Alonso-Vega; Claire Billot; Faustino Torrico
Journal:  PLoS Negl Trop Dis       Date:  2013-07-11

8.  Text message interventions for follow up of infants born to mothers positive for Chagas disease in Tucumán, Argentina: a feasibility study.

Authors:  Gabriela Cormick; Alvaro Ciganda; Maria L Cafferata; Michael J Ripple; Sergio Sosa-Estani; Pierre Buekens; José M Belizán; Fernando Althabe
Journal:  BMC Res Notes       Date:  2015-09-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.